Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- Warminster, Pennsylvania
- Most recent report
- 10-Q, filed Aug 12, 2026
- Filings on record
- 1,000+ filings
- On EDGAR
- CIK 1447028
- Fiscal year ends
- December
- Filer status
- Non-accelerated filer Smaller reporting company
Financials 8 of 178
News 8 of 311
Prospectuses and Registrations 8 of 29
- S-8 Registration statement for an employee plan Jun 5, 2026
- S-3 Shelf registration statement Nov 6, 2024
- S-8 Registration statement for an employee plan Aug 8, 2024
- S-8 Registration statement for an employee plan Aug 3, 2023
- S-8 Registration statement for an employee plan Aug 4, 2022
- 424B5 Prospectus supplement for an offering Mar 3, 2022
- S-3 Shelf registration statement Nov 4, 2021
- 424B5 Prospectus supplement for an offering Oct 8, 2021
Proxies 8 of 35
- DEFA14A Extra proxy material Apr 14, 2026
- DEF 14A Proxy statement for a shareholder vote Apr 14, 2026
- DEFA14A Extra proxy material Apr 4, 2025
- DEF 14A Proxy statement for a shareholder vote Apr 4, 2025
- DEFA14A Extra proxy material Apr 10, 2024
- DEF 14A Proxy statement for a shareholder vote Apr 10, 2024
- DEFA14A Extra proxy material Apr 12, 2023
- DEF 14A Proxy statement for a shareholder vote Apr 12, 2023
Ownership 8 of 380
- SCHEDULE 13G/A Large holder reported a passive stake, amended Aug 12, 2026
- 4 Insider reported a trade Jun 10, 2026
- 4 Insider reported a trade Jun 10, 2026
- SCHEDULE 13G/A Large holder reported a passive stake, amended May 15, 2026
- SCHEDULE 13D/A Large holder reported an active stake, amended Apr 28, 2026
- SCHEDULE 13D/A Large holder reported an active stake, amended Apr 13, 2026
- SCHEDULE 13G/A Large holder reported a passive stake, amended Feb 17, 2026
- SCHEDULE 13G/A Large holder reported a passive stake, amended Feb 11, 2026
Other 8 of 67
- EFFECT Notice that a registration became effective Dec 5, 2024
- CORRESP Reply to SEC staff Dec 2, 2024
- UPLOAD Comment letter from SEC staff Nov 14, 2024
- D Dec 30, 2021
- EFFECT Notice that a registration became effective Nov 18, 2021
- CORRESP Reply to SEC staff Nov 16, 2021
- UPLOAD Comment letter from SEC staff Nov 16, 2021
- EFFECT Notice that a registration became effective Oct 22, 2020
Everything here comes from Arbutus Biopharma Corp's own filings on SEC EDGAR. The filing list is rechecked every hour.